ClinicalTrials.govpublic full text
Impact of CES1 Genotype on Capecitabine Exposure in Cancer Patients
solid cancer, gastric (cardia, body) cancer, esophageal cancer, colorectal cancer (crc), capox, ces1, carboxylesterase 1, capecitabine, pharmacokinetics, pharmacogenetics, oncology, snp
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 879625
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.